Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Volume 20 (2022): Issue 4 (Apr 2022)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines® Insights
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
Oncology Watch
It’s OK to Share!
The Last Word
Chemotherapeutic Shortages: How Do We Prioritize?
Molecular Insights in Patient Care
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition
Original Research
Impact of Allocation on Survival During Intermittent Chemotherapy Shortages: A Modeling Analysis
Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation
Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer
Nonoperative Treatment of Large (5–7 cm), Node-Negative Non–Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines
Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016
Reviews
Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity
Departments
Highlights of the NCCN Oncology Research Program
NCCN News
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/20/4/jnccn.20.issue-4.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[18.97.14.90]
18.97.14.90
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size